Tag: Janssen Pharmaceutica

Johnson & Johnson Hit With $8 Billion Jury Verdict in Risperdal Suit

A Philadelphia jury on Tuesday hit Johnson & Johnson with an $8 billion verdict over its marketing of the anti-psychotic drug Risperdal, siding with a Maryland man who argued that the health care giant downplayed risks that the drug could lead to breast growth in boys. The verdict in the Philadelphia Court of Common Pleas […]

Read More

Johnson & Johnson Reaches Settlement in First Federal Opioids Trial

Johnson & Johnson became the fourth drugmaker to avoid going to trial in the first federal opioids case, announcing Tuesday evening that it had reached a $20.4 million agreement to settle claims raised by two Ohio counties. Although best known for family-friendly products like baby shampoo and baby powder, the company, through its drug manufacturing […]

Read More

Johnson & Johnson Ordered to Pay $572 Million in Landmark Opioid Trial

A judge in Oklahoma on Monday ruled against Johnson & Johnson, the deep-pocketed corporate giant, and ordered it to pay the state $572 million in the first trial of an opioid manufacturer for the destruction wrought by prescription painkillers. Johnson & Johnson, which contracted with poppy growers in Tasmania, supplied 60 percent of the opiate […]

Read More

McKinsey Advised Johnson & Johnson on Increasing Opioid Sales

At the global consulting firm McKinsey & Company, the rule is sacrosanct: Never publicly disclose client advice. And for the most part, adherence to that rule has served the company well. But in recent months, as government officials seek to assign blame for the opioid crisis that has strangled large parts of the nation, McKinsey’s […]

Read More

Oklahoma Faces Off Against J & J in First Trial of an Opioid Maker

Opening statements in the country’s first trial over whether a pharmaceutical company is liable for the opioid crisis began as a battle between fire and ice: Lawyers for Oklahoma, a state brought to its knees by addiction and overdose deaths, heatedly accused Johnson & Johnson of creating a deadly demand for the drugs, while the […]

Read More